Advertisement
Advertisement

MDCX

MDCX logo

Medicus Pharma Ltd. Common Stock

0.43
USD
Sponsored
-0.03
-6.53%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

0.42

-0.01
-1.25%

MDCX Earnings Reports

Positive Surprise Ratio

MDCX beat 2 of 10 last estimates.

20%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.13
Implied change from Q1 26 (Revenue/ EPS)
--
/
-58.06%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-69.05%

Medicus Pharma Ltd. Common Stock earnings per share and revenue

On May 14, 2026, MDCX reported earnings of -0.31 USD per share (EPS) for Q1 26, missing the estimate of -0.19 USD, resulting in a -57.84% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.68% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an decrease of -58.06% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
For Q1 2026, Medicus Pharma Ltd. Common Stock reported EPS of -$0.31, missing estimates by -57.84%, and revenue of $0.00, 0% as expectations.
The stock price moved down -10.68%, changed from $0.34 before the earnings release to $0.30 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on -- analysts, Medicus Pharma Ltd. Common Stock is expected to report EPS of -$0.13 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement